Michael D. Glant

750 total citations
18 papers, 582 citations indexed

About

Michael D. Glant is a scholar working on Genetics, Reproductive Medicine and Surgery. According to data from OpenAlex, Michael D. Glant has authored 18 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 7 papers in Reproductive Medicine and 6 papers in Surgery. Recurrent topics in Michael D. Glant's work include Estrogen and related hormone effects (7 papers), Endometriosis Research and Treatment (5 papers) and Menopause: Health Impacts and Treatments (4 papers). Michael D. Glant is often cited by papers focused on Estrogen and related hormone effects (7 papers), Endometriosis Research and Treatment (5 papers) and Menopause: Health Impacts and Treatments (4 papers). Michael D. Glant collaborates with scholars based in United States, Canada and Belgium. Michael D. Glant's co-authors include Carol Eisenhut, William J. Huster, Michael W. Draper, Ian H. Thorneycroft, Vladimir Hanes, Friedrich C. Luft, Naomi S. Fineberg, Richard L. Kempson, Pincas Bitterman and David F. Archer and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Antimicrobial Agents and Chemotherapy and American Journal of Obstetrics and Gynecology.

In The Last Decade

Michael D. Glant

17 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael D. Glant United States	11	287	209	122	102	91	18	582
Ismael Dale Cotrim Guerreiro da Silva Brazil	18	94 0.3×	66 0.3×	40 0.3×	195 1.9×	90 1.0×	53	668
Christine Kurz Austria	20	62 0.2×	102 0.5×	94 0.8×	525 5.1×	76 0.8×	56	1.2k
Charles N. Carney United States	12	34 0.1×	85 0.4×	135 1.1×	47 0.5×	277 3.0×	14	545
Sommers Sc United States	14	79 0.3×	58 0.3×	68 0.6×	90 0.9×	164 1.8×	47	603
Maria Giulia Santaguida Italy	16	169 0.6×	474 2.3×	28 0.2×	63 0.6×	185 2.0×	30	777
Noritaka Onoda Japan	17	160 0.6×	232 1.1×	130 1.1×	27 0.3×	153 1.7×	29	734
J.M. Malone United States	12	71 0.2×	16 0.1×	74 0.6×	57 0.6×	152 1.7×	23	451
Blaise Robin France	13	34 0.1×	128 0.6×	48 0.4×	34 0.3×	87 1.0×	25	571
Wells Sa United States	13	297 1.0×	173 0.8×	137 1.1×	11 0.1×	329 3.6×	41	847
Rin Chang South Korea	14	69 0.2×	54 0.3×	83 0.7×	13 0.1×	271 3.0×	53	590

Countries citing papers authored by Michael D. Glant

Since Specialization

Citations

This map shows the geographic impact of Michael D. Glant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Glant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Glant more than expected).

Fields of papers citing papers by Michael D. Glant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Glant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Glant. The network helps show where Michael D. Glant may publish in the future.

Co-authorship network of co-authors of Michael D. Glant

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Glant. A scholar is included among the top collaborators of Michael D. Glant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Glant. Michael D. Glant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Cibas, Edmund S., Todd A. Alonzo, R. Marshall Austin, et al.. (2008). The MonoPrep Pap Test for the Detection of Cervical Cancer and Its Precursors. American Journal of Clinical Pathology. 129(2). 193–201. 6 indexed citations

Archer, David F., Ian H. Thorneycroft, Marie L. Foegh, et al.. (2005). Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial. Menopause The Journal of The North American Menopause Society. 12(6). 716–727. 94 indexed citations

Neven, Patrick, Deborah Quail, Christian De Geyter, et al.. (2004). Uterine Effects of Estrogen Plus Progestin Therapy and Raloxifene: Adjudicated Results From the EURALOX Study. Obstetrics and Gynecology. 103(5, Part 1). 881–891. 9 indexed citations

Fugère, P, Wim H. Scheele, Aarti S. Shah, et al.. (2000). Uterine effects of raloxifene in comparison with continuous-combined hormone replacement therapy in postmenopausal women. American Journal of Obstetrics and Gynecology. 182(3). 568–574. 39 indexed citations

Baker, Valerie L., Michael Draper, Sofia Paul, et al.. (1998). Reproductive Endocrine and Endometrial Effects of Raloxifene Hydrochloride, a Selective Estrogen Receptor Modulator, in Women with Regular Menstrual Cycles1. The Journal of Clinical Endocrinology & Metabolism. 83(1). 6–13. 86 indexed citations

Baker, Valerie L., Michael Draper, Sofia Paul, et al.. (1998). Reproductive Endocrine and Endometrial Effects of Raloxifene Hydrochloride, a Selective Estrogen Receptor Modulator, in Women With Regular Menstrual Cycles. Obstetrical & Gynecological Survey. 53(4). 224–226. 3 indexed citations

Shah, Aarti S., Wim H. Scheele, Michael D. Glant, & P Fugère. (1998). Raloxifene HCl is not stimulatory in the endometrium as assessed by the blaustein criteria and an estrogenicity scoring system. Primary Care Update for OB/GYNS. 5(4). 167–167. 4 indexed citations

Glant, Michael D.. (1997). Cytopathology of lymph nodes in nonspecific reactive hyperplasia. Prognostication and differential diagnoses.. PubMed. 108(4 Suppl 1). S31–55. 5 indexed citations

Cramer, Harvey, et al.. (1997). Fine-needle aspiration biopsy of salivary duct carcinoma: Report of five cases. Diagnostic Cytopathology. 16(6). 526–530. 28 indexed citations

10.

Huster, William J., et al.. (1997). Effects of raloxifene hydrochloride on the endometrium of postmenopausal women. American Journal of Obstetrics and Gynecology. 177(6). 1458–1464. 115 indexed citations

11.

Eisenhut, Carol, et al.. (1996). Fine-needle biopsy of pediatric lesions: A three-year study in an outpatient biopsy clinic. Diagnostic Cytopathology. 14(1). 43–50. 18 indexed citations

12.

Eisenhut, Carol, et al.. (1996). Fine‐needle biopsy of pediatric lesions: A three‐year study in an outpatient biopsy clinic. Diagnostic Cytopathology. 14(1). 43–50.

13.

Hull, Meredith T., et al.. (1987). Glycogen-rich Clear Cell Carcinoma of the Urethra: An Ultrastructural Study. Ultrastructural Pathology. 11(4). 421–427. 10 indexed citations

14.

Moriarty, Ann, Michael D. Glant, & Frederick B. Stehman. (1986). The role of fine needle aspiration cytology in the management of gynecologic malignancies.. PubMed. 30(1). 59–64. 19 indexed citations

15.

Sledge, George W., Michael D. Glant, Jan Jansen, et al.. (1986). Establishment in long term culture of megakaryocytic leukemia cells (EST-IU) from the marrow of a patient with leukemia and a mediastinal germ cell neoplasm.. PubMed. 46(4 Pt 2). 2155–9. 37 indexed citations

16.

Fiore, Andrew C., Pamela S. Peigh, Robert J. Robison, et al.. (1983). Valved and nonvalved right ventricular--pulmonary arterial extracardiac conduits. An experimental comparison.. PubMed. 86(4). 490–7. 24 indexed citations

17.

Aronoff, George R., S T Pottratz, Michael E. Brier, et al.. (1983). Aminoglycoside accumulation kinetics in rat renal parenchyma. Antimicrobial Agents and Chemotherapy. 23(1). 74–78. 44 indexed citations

18.

Aronoff, George R., et al.. (1981). Effects of vancomycin on renal function in rats. Antimicrobial Agents and Chemotherapy. 19(2). 306–308. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact